Applied DNA Sciences Inc (APDN)
3.75
-0.34
(-8.31%)
USD |
NASDAQ |
May 03, 16:00
3.785
+0.04
(+0.93%)
Pre-Market: 20:00
Applied DNA Sciences Free Cash Flow (Quarterly): -3.758M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.758M |
| September 30, 2023 | -2.542M |
| June 30, 2023 | -1.531M |
| March 31, 2023 | 0.16M |
| December 31, 2022 | -2.383M |
| September 30, 2022 | -3.501M |
| June 30, 2022 | -1.831M |
| March 31, 2022 | -0.3274M |
| December 31, 2021 | -3.807M |
| September 30, 2021 | -5.618M |
| June 30, 2021 | -1.753M |
| March 31, 2021 | -4.080M |
| December 31, 2020 | -4.485M |
| September 30, 2020 | -3.991M |
| June 30, 2020 | -3.02M |
| March 31, 2020 | -2.465M |
| December 31, 2019 | -2.731M |
| September 30, 2019 | -1.776M |
| June 30, 2019 | -1.288M |
| March 31, 2019 | -2.300M |
| December 31, 2018 | -1.566M |
| September 30, 2018 | -2.505M |
| June 30, 2018 | -1.195M |
| March 31, 2018 | -0.8621M |
| December 31, 2017 | -2.621M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.948M |
| June 30, 2017 | -1.884M |
| March 31, 2017 | -2.681M |
| December 31, 2016 | -2.112M |
| September 30, 2016 | -2.594M |
| June 30, 2016 | -2.699M |
| March 31, 2016 | -2.603M |
| December 31, 2015 | -2.787M |
| September 30, 2015 | -1.918M |
| June 30, 2015 | -1.482M |
| March 31, 2015 | -1.849M |
| December 31, 2014 | -2.356M |
| September 30, 2014 | -2.242M |
| June 30, 2014 | -2.008M |
| March 31, 2014 | -2.196M |
| December 31, 2013 | -2.066M |
| September 30, 2013 | -2.596M |
| June 30, 2013 | -1.991M |
| March 31, 2013 | -2.179M |
| December 31, 2012 | -1.740M |
| September 30, 2012 | -1.090M |
| June 30, 2012 | -1.143M |
| March 31, 2012 | -1.079M |
| December 31, 2011 | -0.8115M |
| September 30, 2011 | -1.561M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-5.618M
Minimum
Sep 2021
0.16M
Maximum
Mar 2023
-2.670M
Average
-2.542M
Median
Sep 2023
Free Cash Flow (Quarterly) Benchmarks
| Fonar Corp | 3.938M |
| XWELL Inc | -3.467M |
| ProPhase Labs Inc | -1.523M |
| Veracyte Inc | 13.06M |
| OncoCyte Corp | -4.826M |